Results 251 to 260 of about 2,714,339 (309)

Promoter (4G/5G) Plasminogen Activator Inhibitor-1 Genotype and Plasminogen Activator Inhibitor-1 Levels in Blacks, Hispanics, and Non-Hispanic Whites

Circulation, 2003
Russell Tracy, Stephen Rich, Nancy S Jenny   +2 more
exaly  

Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase

Cell, 2017
Richard H Ebright, Yu Zhang, Stefano Donadio   +2 more
exaly  

Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence

Arteriosclerosis, Thrombosis, and Vascular Biology, 2017
Asish Ghosh, Douglas Vaughan, Sadiya Khan   +2 more
exaly  

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks

Journal of Allergy and Clinical Immunology, 2009
Avner Reshef, Jonathan Bernstein, Bruce Ritchie   +2 more
exaly  

DUTPASE INHIBITORS

2005
GILBERT IAN, NGUYEN CORINNE, RUDA GIAN FILIPPO, SCHIPANI ALESSANDRO, KASINATHAN GANASAN, JOHANSSON NILS-GUNNAR, PACANOWSKA DOLORES GONZALEZ   +6 more
openaire   +5 more sources

Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency

Journal of Allergy and Clinical Immunology, 2006
G Choi, Goda Choi
exaly  

Inhibitors of caspases

1999
WANNAMAKER MARION W, BEMIS GUY W, CHARIFSON PAUL S, LAUFFER DAVID J, MULLICAN MICHAEL D, MURCKO MARK A, WILSON KEITH P, JANETKA JAMES W, DAVIES ROBERT J, GRILLOT ANNE-LAURE, SHI ZHAN, FORSTER CORNELIA J   +11 more
openaire   +16 more sources

A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors

Annals of Oncology, 2015
J R Infante, J C Bendell, D Rasco
exaly  

Tissue Factor Pathway Inhibitor

Arteriosclerosis, Thrombosis, and Vascular Biology, 2016
Alan E Mast
exaly  

Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis

Circulation, 2017
Daniel Lee, Paul Burridge, Asish Ghosh   +2 more
exaly